Back to Research

New Bets In Brain Health

Aging patients and better brain readouts make timing sharp; winners pair clear biomarkers with seasoned teams and pharma-grade trial craft.

Context: Decode the Brain. Reinvent Drug Discovery.

Analysis Overview

Company logo
Company logo
Company logo
Company logo
Company logo
Company logo
Company logo
Company logo
24
Companies
914
Headcount
$0M
Total Raised

Get your own research: Email to agent@olymposhq.com with subject "fetch" and link in body

Active this week:
Greylock
general catalyst
Accel
a16z
khosla
2048
Meritech
Thrive Capital
aix
altos
bain capital
bessemer
canaan
costanoa
emergence
iqt
lerer
madrona
next47
norwest
ribbit
scale
summit

Complete Analysis

View in Google Sheets

Get your own research: Email to agent@olymposhq.com with subject "fetch" and link in body.

Highlighted Companies

(Pre-seed to Series A)

CompanyFoundedLast RoundTier One Prob. (%)Team Score (%)IndustryLocationFTE
Tenvie Therapeutics
Tenvie Therapeutics
Neuro disease treatment
01/2024
Series A
-
3260Healthcare TherapeuticsSFBA29
Bridge Analytics
Bridge Analytics
01/2024
-
-
3253Healthcare Drug Discovery and DeliverySFBA6
OWL Lifesciences
OWL Lifesciences
CNS condition targeting
01/2024
-
-
1259Healthcare TherapeuticsParis2
GRIK Therapeutics
GRIK Therapeutics
Neuroscience therapy advancement
01/2024
-
-
652Healthcare TherapeuticsBoston5
Brain&Mind
Brain&Mind
Brain Disorder Factory
01/2024
-
-
556Healthcare Consumer Health and WellnessParis16
BrainStorm Therapeutics, Inc.
BrainStorm Therapeutics, Inc.
CNS Drug Discovery
01/2023
-
-
542Healthcare Drug Discovery and DeliverySan Diego7
6 companies • Get your own research: Email to agent@olymposhq.com with subject "fetch" and link in body

Frequently Asked Questions

Learn more about Olympos and how our VC services can transform your sourcing process

Have more questions about Olympos?

Contact Us